Corrigendum to: " CLOCK gene circannual expression in cluster headache".
- Published in:
- 2024
- Publication type:
- Correction Notice
Works matching IS 03331024 AND DT 2024 AND VI 44 AND IP 12
Results: 8
1
2
Communicate your findings with graphical abstract in Cephalalgia : Why and how?
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
3
Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-blind, randomized, phase 3 trials.
- Published in:
- Cephalalgia, 2024, v. 44, n. 12, p. 1, doi. 10.1177/03331024241300305
- By:
- Publication type:
- Article
4
Weight loss with atogepant during the preventive treatment of migraine: A pooled analysis.
- Published in:
- Cephalalgia, 2024, v. 44, n. 12, p. 1, doi. 10.1177/03331024241299753
- By:
- Publication type:
- Article
5
Methodology of drug trials in migraine: History and suggestions for the future.
- Published in:
- Cephalalgia, 2024, v. 44, n. 12, p. 1, doi. 10.1177/03331024241298642
- By:
- Publication type:
- Article
6
Abstracts of the 20 th Biennial Migraine Trust International Symposium, London UK, 5th to 8th September 2024.
- Published in:
- Cephalalgia, 2024, v. 44, n. 12, p. 1, doi. 10.1177/03331024241280496
- Publication type:
- Article
7
The incremental burden and healthcare resource utilization among people with migraine in Europe: Insights from the 2020 European National Health and Wellness Survey.
- Published in:
- Cephalalgia, 2024, v. 44, n. 12, p. 1, doi. 10.1177/03331024241276415
- By:
- Publication type:
- Article
8
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine.
- Published in:
- Cephalalgia, 2024, v. 44, n. 12, p. 1, doi. 10.1177/03331024241262751
- By:
- Publication type:
- Article